MindBio Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 26, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	5	3	5	9	-
Market Cap Growth	70.49%	-46.64%	-42.86%	-	-
Enterprise Value	6	7	10	-	-
Last Close Price	0.96	2.00	16.00	28.00	-
PB Ratio	-2.49	-1.30	-1.08	-1.95	-
Debt / Equity Ratio	-0.90	-0.92	-0.92	-0.92	-1.06
Net Debt / Equity Ratio	-0.89	-0.89	-0.89	-0.86	-0.74
Net Debt / EBITDA Ratio	-	-1.22	-	-	-0.59
Quick Ratio	0.03	0.05	0.04	0.13	1.17
Current Ratio	0.03	0.05	0.04	0.23	1.35
Return on Assets (ROA)	-2079.78%	-764.50%	-91.41%	-175.93%	-
Return on Capital Employed (ROCE)	122.20%	77.80%	12.40%	142.90%	-1284.90%
Earnings Yield	-119.29%	-88.39%	-7.05%	-40.57%	-
Buyback Yield / Dilution	-98.05%	-54.23%	-20.80%	-106.14%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.